Premera is no longer requiring prior authorization and medical necessity review for three genetic tests in newborns. This means that starting October 6, 2019, our providers don’t need to submit requests through our partner AIM Specialty Health® (AIM) when the following codes are submitted individually or with each other.
Larger panels including these tests and other genetic testing services for newborns may still require prior authorization. Providers can find the review requirements by using our code check tool, code list, or prior auth tool.
Email this article
Back to News